Previous studies had linked IL-15 production with TNF-α stimulation of secreting cells [34], and TNF-α-targeted therapies have been shown to reduce serum IL-15 levels in patients with rheumatic diseases [35,36]. Here, TNF is linked to rheumatic disorder.